James (Jim) Linder, MD, is the chief executive officer for Nebraska Medicine and professor of pathology for the University of Nebraska Medical Center (UNMC).

After earning his medical degree from UNMC in Omaha, Nebraska, and subsequent training in pathology at Duke University in Durham, North Carolina, he joined the UNMC faculty in 1983. Dr. Linder has authored more than 150 publications and five textbooks while filling diverse roles in academic medicine and business. He has led professional organizations including being president of the American Society of Clinical Pathologists, Council of the American Society of Cytopathology, and the American Medical Association’s Residency Review Committee for Pathology.

Dr. Linder served as interim dean of the College of Medicine and associate vice chancellor for research, both for UNMC; and interim president of the University of Nebraska system. From 2010, until joining Nebraska Medicine, he served as president of the University Technology Development Corporation where he led technology transfer, public-private partnerships and specialized research.

In the commercial sector, his research as chief medical officer for Cytyc Corporation led to new cancer screening technologies that reduced the incidence of cervical cancer. As co-founder of Constitution Medical, a new hematology instrument was developed to enable the rapid diagnosis of blood disorders. His research led to induction into the National Academy of Inventors.
His business experience led to the founding of Linseed Capital with his wife, Karen. The Linders have received awards for supporting entrepreneurship and are members of the Omaha Business Hall of Fame.